SARS-CoV-2

SARS-CoV-2, a virus from the coronaviridae family, is responsible for causing the novel coronavirus disease (COVID-19), which has emerged as a global pandemic. The virus was first identified in Wuhan, China, in December 2019 and has since spread rapidly across the world, infecting millions of people. SARS-CoV-2 is a highly infectious virus that spreads through respiratory droplets when an infected person coughs, sneezes, or talks. The virus primarily targets the respiratory system, causing symptoms such as fever, cough, shortness of breath, and fatigue. However, some infected individuals may also experience gastrointestinal symptoms or lose their sense of taste and smell. The virus enters human cells by binding to the angiotensin-converting enzyme 2 (ACE2) receptor, which is found predominantly in the respiratory and digestive systems. Once inside the cell, the virus replicates rapidly and triggers an immune response, leading to inflammation and tissue damage. In addition to the acute respiratory distress syndrome (ARDS), SARS-CoV-2 has been linked to several other complications, including pneumonia, acute kidney injury, and cardiovascular diseases. Older adults and people with pre-existing medical conditions, such as diabetes and hypertension, are most vulnerable to severe illness and death from COVID-19. Efforts to combat the pandemic include vaccination campaigns, social distancing, and the use of personal protective equipment (PPE). Ongoing research is focused on understanding the epidemiology, pathogenesis, and potential treatments for SARS-CoV-2. The International Journal of Coronaviruses provides a platform for scientists, researchers, and healthcare professionals to publish and access the latest research findings on this virus and other coronaviruses.

Related Articles

11 article(s) found
Presentation of Neutralizing Antibodies in Single- or Pooled-Convalescent Immune Plasma from Donors to Prevent the Current SARS-CoV-2 Pandemic
Full-text HTML Download PDF Download XML
SARS-CoV-2 affected cells Pathogeny and Therapy
Full-text HTML Download PDF Download XML
Analytical Solutions of the Transmissibility of the SARS-CoV-2 in Three Interactive Populations
Full-text HTML Download PDF Download XML
Molecular Evolutionary Characteristics of the 2019 Novel Coronavirus (SARS-CoV-2) Contracted by Tunisian Citizens : Comparison and Relationship to Other Human and Animal Coronaviruses Based on Spike Glycoprotein-Coding Gene Sequences Analysis
Full-text HTML Download PDF Download XML
An Algorithm to Predict the Possible SARS-CoV-2 Mutations
Full-text HTML Download PDF Download XML
Molecular Evolution of the Novel Coronavirus SARS-CoV-2
Full-text HTML Download PDF Download XML
Use of the Remaining Sample from the Panbio COVID-19 Antigen Rapid Test Device for the Molecular Screening of the SARS-CoV-2 Variant of Concern B.1.1.7
Full-text HTML Download PDF Download XML
SARS-Cov-2 Viral Kinetics in Mild COVID-19 Patients Treated with Chloroquine Regimens or Standard of Care
Full-text HTML Download PDF Download XML
First Analytical Solution of Intracellular life Cycle of SARS-CoV-2
Full-text HTML Download PDF Download XML
Marginal SARS-CoV-2 Spike Protein Increases Interferon and Balances Cytokine Gene Expression
Full-text HTML Download PDF Download XML
Pyrexia And Liver Injury After A Second SARS-CoV-2 Vaccination: Macrophage Activation Manifested In Liver
Full-text HTML Download PDF Download XML